Dunia Zoma, | |
30920 Southfield Rd, Southfield, MI 48076-7738 | |
(248) 647-7472 | |
Not Available |
Full Name | Dunia Zoma |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 30920 Southfield Rd, Southfield, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013692573 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 5302415196 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dunia Zoma, 30920 Southfield Rd, Southfield, MI 48076-7738 Ph: (248) 647-7472 | Dunia Zoma, 30920 Southfield Rd, Southfield, MI 48076-7738 Ph: (248) 647-7472 |
News Archive
Alnylam Pharmaceuticals, Inc. and Genzyme, a Sanofi company, announced today that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin (TTR) for the treatment of transthyretin-mediated amyloidosis (ATTR) in Japan and other Asia-Pacific countries.
People who are diagnosed with cancer have a markedly increased risk of suicide and cardiovascular death during the period immediately after being given the diagnosis. This has been shown in a new study from Karolinska Institutet in Sweden, published in the prestigious scientific journal The New England Journal of Medicine.
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
Researchers at Le Bonheur Children's Hospital and the University of Tennessee Health Science Center announced results of a clinical trial of a new drug shown to safely reduce the viral load and clinical illness of healthy adult volunteers intranasally infected with respiratory syncytial virus (RSV).
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
› Verified 8 days ago
Marcy L Epstein, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22250 Providence Dr, Southfield, MI 48075 Phone: 248-849-3945 Fax: 248-849-8601 | |
Mr. Boby Abraham, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23111 Lahser Road, Walgreens, Southfield, MI 48034 Phone: 248-945-9216 | |
Dina Issa, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26026 W 12 Mile Rd # Oad, Southfield, MI 48034 Phone: 248-350-0280 | |
Mrs. Bonita Simcha Bohl, R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21298 Melrose Avenue, Southfield, MI 48075 Phone: 248-827-3370 Fax: 248-827-3375 | |
Carl Ndangoh, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 Towne Sq, Southfield, MI 48076 Phone: 313-208-7376 | |
Donna K Spencer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26776 W 12 Mile Rd Ste 108, Southfield, MI 48034 Phone: 248-356-9732 |